A notable double-blind RCT in 262 elderly subjects found that NAC (600 mg twice daily) for 6 months significantly reduced influenza-like episodes only 25% of NAC-treated subjects who seroconverted to influenza A developed clinical symptoms, compared to 79% of placebo subjects (De Flora et al., Eur Respir J, 1997) [40]
Miami has a large, active population: athletes, gym-goers, people recovering from sports injuries, and patients dealing with chronic gut issues that never fully resolved
In user trials, 91% of participants reported a visible glow and 87% saw a reduction in pigmentation and dullness after 6 weeks of regular use
These studies were published between 2022 and 2025, with two studies in 2022, three each in 2023 and 2024, and one in 2025